c-di-AMP; Cyclic di-AMP; 54447-84-6; Cyclic diadenylate; Cyclic-di-AMP; CHEBI:71578; 3',5'-cyclic di-AMP; WH9B66EIX2; 3',5'-Cyclic diadenylic acid; CHEMBL1229884; cyclic di-3',5'-adenylic acid; bis(3',5')-cyclic diadenylic acid; (1S,6R,8R,9R,10S,15R,17R,18R)-8,17-bis(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol; 126877-05-2; bis-(3'-5')-cyclic dimeric adenosine monophosphate; 3'-Adenylic acid, adenylyl-(3'->5')-, cyclic nucleotide; Cyclic di-3',5'-adenylate; (2R,3R,3aS,7aR,9R,10R,10aS,14aR)-2,9-bis(6-amino-9H-purin-9-yl)octahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-3,5,10,12-tetrol 5,12-dioxide; Acetic acid, 4-(2,6-dihydro-2,6-dioxo-7-phenylbenzo1,2-b:4,5-bdifuran-3-yl)phenoxy-, 2-ethoxyethyl e; (2R,3R,3aS,5R,7aR,9R,10R,10aS,12R,14aR)-2,9-bis(6-amino-9H-purin-9-yl)octahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8 ]tetraoxadiphosphacyclododecine-3,5,10,12-tetrol 5,12-dioxide; (2r,3r,3as,5r,7ar,9r,10r,10as,12r,14ar)-2,9-Bis(6-Amino-9h-Purin-9-Yl)octahydro-2h,7h-Difuro[3,2-D:3',2'-J][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-3,5,10,12-Tetrol 5,12-Dioxide; 2BA; UNII-WH9B66EIX2; c-Di-AMP(Cyclic-Di-AMP); SCHEMBL18700333; DTXSID201317771; EX-A3317; BDBM50509429; ZINC58661162; CS-3325; HY-12326; C20565; bis-(3',5')-cyclic-dimeric-Adenosine-monophosphate; Q27139726; (1S,6R,8R,9R,10S,15R,17R,18R)-8,17-bis(6-amino-9H-purin-9-yl)-3,9,12,18-tetrahydroxy-2,4,7,11,13,16-hexaoxa-3,12-diphosphatricyclo[13.3.0.0,octadecane-3,12-dione; (2R,3R,3aS,7aR,9R,10R,10aS,14aR)-2,9-bis(6-amino-9H-purin-9-yl)-3,5,10,12-tetrahydroxyoctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9]tetraoxa[2,8]diphosphacyclododecine 5,12-dioxide